NCT00413322 2015-07-08
Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors
Valerio Therapeutics
Phase 1 Completed
Valerio Therapeutics
National Cancer Institute (NCI)
National Cancer Institute (NCI)